Literature DB >> 18979121

Ataxia and pancytopenia caused by a mutation in TINF2.

Elena Tsangaris1, Sally-Lin Adams, Grace Yoon, David Chitayat, Peter Lansdorp, Inderjeet Dokal, Yigal Dror.   

Abstract

The syndrome of ataxia-pancytopenia is an autosomal dominant disorder characterized by cerebellar ataxia, peripheral neuropathies, pancytopenia and a predilection to myelodysplastic syndrome and acute myeloid leukemia. The genetic basis of this condition is unknown. We describe a child who presented with ataxia and pancytopenia and was found to have a heterozygous mutation, c.845G>A (Arg282His) in TINF2, a gene recently reported to be mutated in a subset of patients with autosomal dominant dyskeratosis congenita. We propose that some cases of ataxia-pancytopenia may be affected by DC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979121     DOI: 10.1007/s00439-008-0576-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Authors:  N S Heiss; S W Knight; T J Vulliamy; S M Klauck; S Wiemann; P J Mason; A Poustka; I Dokal
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

3.  Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.

Authors:  Tom J Vulliamy; Amanda Walne; Aroon Baskaradas; Philip J Mason; Anna Marrone; Inderjeet Dokal
Journal:  Blood Cells Mol Dis       Date:  2005 May-Jun       Impact factor: 3.039

4.  Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients.

Authors:  Stephanie King; Manuela Germeshausen; Gabriele Strauss; Karl Welte; Matthias Ballmaier
Journal:  Br J Haematol       Date:  2005-12       Impact factor: 6.998

5.  Aplastic anemia in a patient with Rothmund-Thomson syndrome.

Authors:  K A Knoell; N K Sidhu-Malik; R K Malik
Journal:  J Pediatr Hematol Oncol       Date:  1999 Sep-Oct       Impact factor: 1.289

6.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

7.  Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.

Authors:  Blanche P Alter; Gabriela M Baerlocher; Sharon A Savage; Stephen J Chanock; Babette B Weksler; Judith P Willner; June A Peters; Neelam Giri; Peter M Lansdorp
Journal:  Blood       Date:  2007-04-27       Impact factor: 22.113

8.  Ataxia-pancytopenia: syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia.

Authors:  F P Li; F Hecht; B Kaiser-McCaw; P V Baranko; N U Potter
Journal:  Cancer Genet Cytogenet       Date:  1981-11

9.  Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.

Authors:  Amanda J Walne; Tom Vulliamy; Anna Marrone; Richard Beswick; Michael Kirwan; Yuka Masunari; Fat-Hia Al-Qurashi; Mahmoud Aljurf; Inderjeet Dokal
Journal:  Hum Mol Genet       Date:  2007-05-16       Impact factor: 6.150

10.  TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.

Authors:  Amanda J Walne; Tom Vulliamy; Richard Beswick; Michael Kirwan; Inderjeet Dokal
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

View more
  18 in total

Review 1.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

2.  Positional cloning and next-generation sequencing identified a TGM6 mutation in a large Chinese pedigree with acute myeloid leukaemia.

Authors:  Li-Li Pan; Yuan-mao Huang; Min Wang; Xiao-e Zhuang; Dong-feng Luo; Shi-cheng Guo; Zhi-shun Zhang; Qing Huang; Sheng-long Lin; Shao-yuan Wang
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

Review 3.  Telomere dysfunction in human bone marrow failure syndromes.

Authors:  Ludmila Shtessel; Shawn Ahmed
Journal:  Nucleus       Date:  2011 Jan-Feb       Impact factor: 4.197

4.  Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.

Authors:  G S Sasa; A Ribes-Zamora; N D Nelson; A A Bertuch
Journal:  Clin Genet       Date:  2011-04-07       Impact factor: 4.438

5.  Telomere dysfunction in human diseases: the long and short of it!

Authors:  Kathryn A Carroll; Hinh Ly
Journal:  Int J Clin Exp Pathol       Date:  2009-05-10

6.  Dyskeratosis congenita.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

7.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.

Authors:  Dong-Hui Chen; Jennifer E Below; Akiko Shimamura; Sioban B Keel; Mark Matsushita; John Wolff; Youngmee Sul; Emily Bonkowski; Maria Castella; Toshiyasu Taniguchi; Deborah Nickerson; Thalia Papayannopoulou; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

Review 8.  Telomeres and telomerase: three decades of progress.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Nat Rev Genet       Date:  2019-05       Impact factor: 53.242

9.  Telomere protection by TPP1/POT1 requires tethering to TIN2.

Authors:  Kaori K Takai; Tatsuya Kibe; Jill R Donigian; David Frescas; Titia de Lange
Journal:  Mol Cell       Date:  2011-11-18       Impact factor: 19.328

10.  Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas.

Authors:  Sebastian Begemann; Francesco Galimi; Jan Karlseder
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.